Back to search

Article

Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatment

2022-03-08

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Aromatase inhibitor (AI)-induced joint pain is a common toxicity of AIs treatment. It has believed that the genetic variation at population level is associated with the phenotype of joint pain. Given the differences of genetic structure in different ethnicities and the limited information about AI-induced joint pain in Chinese breast cancer survivors, this cross...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
61d77262-8f55-5332-93dd-79997530e0be
DOI
10.21203/rs.3.rs-1390711/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prevalence and correlates of joint pain among Chinese breast cancer survivors receiving aromatase inhibitor treatmentDOI 10.21203/rs.3.rs-1390711/v1
ESR1 polymorphisms were associated with aromatase inhibitors induced musculoskeletal symptoms in breast cancer patients.Semantic proximity
Indications of clinical and genetic predictors for aromatase inhibitors related musculoskeletal adverse events in Chinese Han women with breast cancer.Semantic proximity
RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients.Semantic proximity
Does Kashin-beck Disease Present Only Multisite Pain? A Cross-sectional Study of Pain Characteristics in Northwest ChinaSemantic proximity
Regulatory VCAN Polymorphism is Associated with Shoulder Pain and Disability in Breast Cancer SurvivorsSemantic proximity
Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.Semantic proximity
Genetics of Chronic Shoulder Pain/Disability in South African Breast Cancer Survivors: Polygenic Contributions by Opioid and Pain Signaling Pathways.Semantic proximity
Clinical and genetic risk factors for aromatase inhibitor-associated arthralgia in breast cancer survivors.Semantic proximity
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms.Semantic proximity
ABCB1 and OPRM1 single-nucleotide polymorphisms collectively modulate chronic shoulder pain and dysfunction in South African breast cancer survivors.Semantic proximity
Phenotyping of chronic pain in breast cancer survivors: an original study using the cancer pain phenotyping (CANPPHE) Network multidisciplinary international guidelines.Semantic proximity
Risk factors and related miRNA phenotypes of chronic pain after thoracoscopic surgery in lung adenocarcinoma patientsSemantic proximity
Select a neighboring publication to make it the new centre.